SM

Santha Mahalakshmi Padala

Active Director Director DIN 10937561
DIN 10937561 First appointment Feb 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Santha Mahalakshmi Padala

Data last updated:

Santha Mahalakshmi Padala is a Director at Akamei Pharmaceuticals Private Limited (since 2025). The company operates in Paper.

DIN 10937561
Primary Designation Director
Industry Paper
First Appointment 04 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Feb 20252025Active

Directorship timeline

Open interactive timeline →
Akamei Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Santha Mahalakshmi Padala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santha Mahalakshmi Padala

Santha Mahalakshmi Padala currently holds 1 directorship: Akamei Pharmaceuticals Private Limited (Director, since 04 Feb 2025).

Santha Mahalakshmi Padala was first appointed on 04 Feb 2025 as Director at Akamei Pharmaceuticals Private Limited.

The current boards of Santha Mahalakshmi Padala's companies include Nallamilli Chaitanya Chandra Reddy (Akamei Pharmaceuticals Private Limited), Nallamilli Karthik Sai Kumar Reddy (Akamei Pharmaceuticals Private Limited), Ravi Bellamkonda (Akamei Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available